Literature DB >> 35096320

Identification of other Cellular Receptors for Edema Factor of Bacillus anthracis by Independent Inhibition of Protective Antigen Evidenced by Inhibition of Embryo Growth and Angiogenesis.

R Khandia1,2, B Pattnaik3, K Rajukumar1, A K Pateriya1, N Puranik2, S Bhatia1, H Murugkar1.   

Abstract

Edema factor (EF) is one of the major secretory proteins of anthrax bacteria along with protective antigen (PA) and lethal factor (LF). Edema factor is a calmodulin-and calcium-dependent adenylate cyclase that increases intracellular levels of cAMP. Intracellular trafficking of EF occurs through PA by binding to ATR/CMG2 receptors, which are also involved in other physiological functions of cells. cAMP is a secondary messenger which activates multiple signaling cascades involved in the cytokinetics of actin molecules and cell junction formation. The present study evaluated the effect of EF on growth and angiogenesis patterns in chicken embryos in the in ovo model. Angiogenesis in the chorioallantoic membrane (CAM) of an embryonated chicken egg was decreased and embryo growth was delayed by EF despite the absence of trafficking moiety PA, which is required for transferring the EF molecule inside the cell. Angiogenesis inhibition and embryo growth retardation indicate the use of an alternative receptor by EF to modulate these cellular functions. Additionally, docking was performed between EF as a ligand and hepatocyte growth factor receptor (cMET) and vascular endothelial growth factor (VEGF) receptors, which are mainly involved in growth and angiogenesis. The analysis revealed a very strong binding of EF to cMET receptor (in terms of the number of hydrogen bonds and energy) compared to its ligand hepatocyte growth factor (HGF), which indicates the use of cMET receptor by EF and induction of angiogenesis and embryo growth retardation possibly by competitive inhibition of HGF ligand or receptor-mediated endocytosis.

Entities:  

Keywords:  Angiogenesis inhibition; CAM; Edema factor; Embryo growth retardation; Signaling molecule; cAMP

Mesh:

Substances:

Year:  2021        PMID: 35096320      PMCID: PMC8790966          DOI: 10.22092/ari.2021.355959.1756

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  15 in total

1.  Inhibition of endothelial cell survival and angiogenesis by protein kinase A.

Authors:  Semi Kim; Manjiri Bakre; Hong Yin; Judith A Varner
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

Authors:  John A T Young; R John Collier
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

3.  Identification of the cellular receptor for anthrax toxin.

Authors:  K A Bradley; J Mogridge; M Mourez; R J Collier; J A Young
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

4.  Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis.

Authors:  C P Quinn; Y Singh; K R Klimpel; S H Leppla
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

5.  Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines.

Authors:  H Tajima; K Matsumoto; T Nakamura
Journal:  FEBS Lett       Date:  1991-10-21       Impact factor: 4.124

6.  cAMP inhibits TGFbeta1-induced in vitro angiogenesis.

Authors:  Beatriz del Valle-Pérez; Ofelia Maria Martínez-Estrada; Senén Vilaró; Francesc Ventura; Francesc Viñals
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

7.  Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles.

Authors:  Shixing Tang; Mahtab Moayeri; Zhaochun Chen; Harri Harma; Jiangqin Zhao; Haijing Hu; Robert H Purcell; Stephen H Leppla; Indira K Hewlett
Journal:  Clin Vaccine Immunol       Date:  2009-01-07

8.  Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.

Authors:  N A Lokker; M R Mark; E A Luis; G L Bennett; K A Robbins; J B Baker; P J Godowski
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

9.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

Authors:  L Naldini; K M Weidner; E Vigna; G Gaudino; A Bardelli; C Ponzetto; R P Narsimhan; G Hartmann; R Zarnegar; G K Michalopoulos
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met.

Authors:  Cristina Basilico; Addolorata Arnesano; Maria Galluzzo; Paolo M Comoglio; Paolo Michieli
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.